DELVINO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 3.778
NA - Nord America 2.031
EU - Europa 1.625
SA - Sud America 705
AF - Africa 91
OC - Oceania 19
Totale 8.249
Nazione #
US - Stati Uniti d'America 1.904
SG - Singapore 995
CN - Cina 727
IT - Italia 695
VN - Vietnam 689
BR - Brasile 531
HK - Hong Kong 492
RU - Federazione Russa 343
JP - Giappone 174
BD - Bangladesh 155
FR - Francia 123
KR - Corea 119
IN - India 103
GB - Regno Unito 81
DE - Germania 76
AR - Argentina 71
ES - Italia 60
TR - Turchia 59
CA - Canada 58
ID - Indonesia 51
IQ - Iraq 44
MX - Messico 39
SE - Svezia 39
NL - Olanda 31
PK - Pakistan 27
VE - Venezuela 25
ZA - Sudafrica 25
CO - Colombia 24
SA - Arabia Saudita 24
FI - Finlandia 23
UA - Ucraina 23
EC - Ecuador 22
CH - Svizzera 21
PL - Polonia 18
UZ - Uzbekistan 18
IE - Irlanda 17
AU - Australia 16
AT - Austria 14
MA - Marocco 13
CL - Cile 12
KE - Kenya 12
PH - Filippine 12
TW - Taiwan 12
BE - Belgio 10
EG - Egitto 10
TH - Thailandia 10
LB - Libano 9
AZ - Azerbaigian 8
AL - Albania 7
CR - Costa Rica 7
JM - Giamaica 7
TN - Tunisia 7
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
QA - Qatar 4
BO - Bolivia 3
HN - Honduras 3
KZ - Kazakistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
AO - Angola 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GE - Georgia 2
NO - Norvegia 2
OM - Oman 2
RE - Reunion 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
DM - Dominica 1
GH - Ghana 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 8.239
Città #
Singapore 545
Hong Kong 482
San Jose 341
Ashburn 289
Hefei 243
Ho Chi Minh City 212
Hanoi 198
Milan 194
Seoul 114
Beijing 88
Los Angeles 81
The Dalles 80
Chicago 70
Dallas 68
Rome 68
Tokyo 55
Ann Arbor 54
Lauterbourg 50
New York 50
Moscow 44
São Paulo 44
Turin 44
Santa Clara 43
Buffalo 39
Shanghai 36
Jakarta 32
Council Bluffs 25
Toronto 25
Da Nang 23
Paris 22
Madrid 21
Rio de Janeiro 20
Biên Hòa 19
Boardman 18
Frankfurt am Main 18
Haiphong 18
Dublin 17
Florence 17
Osaka 17
Quận Bình Thạnh 17
Tashkent 17
Baghdad 16
Guangzhou 15
Belo Horizonte 14
Orem 14
Ankara 13
Chennai 13
Hải Dương 13
Istanbul 13
London 13
Mexico City 13
Riyadh 13
Amsterdam 12
Buenos Aires 12
Montreal 12
Stockholm 12
Caracas 11
Johannesburg 11
Kent 11
Mumbai 11
Quito 11
Ryōke 11
Carate Brianza 10
Charlotte 10
Denver 10
Lappeenranta 10
Nairobi 10
Nuremberg 10
Seattle 10
Atlanta 9
Dhaka 9
Munich 9
Salt Lake City 9
Salvador 9
Vienna 9
Bogotá 8
Brasília 8
Brooklyn 8
Columbus 8
Ha Long 8
Helsinki 8
Houston 8
Manaus 8
Manchester 8
Recife 8
Ribeirão Preto 8
Vũng Tàu 8
Warsaw 8
Baku 7
Bologna 7
Boston 7
Brescia 7
Brussels 7
Jeddah 7
Matsuyama 7
Newark 7
Ninh Bình 7
San José 7
Taiyuan 7
Trento 7
Totale 4.434
Nome #
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 582
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study 333
Systemic vasculitis: one year in review 2024 301
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 298
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 241
Approccio innovativo agli unmet needs nella gestione a lungo termine dei pazienti affetti da vasculite ANCA-associata 229
Novel insights into the management of rheumatoid arthritis: one year in review 2024 213
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 202
Systemic vasculitis: one year in review 2022 201
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 188
Systemic vasculitis: one year in review 2025 185
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 173
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 169
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 160
Clinical picture, outcomes and predictors of relapse in eosinophilia-associated coronary vasospasm: data from a European multicentric study 158
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polangiitis in a patient treated with dupilumab 148
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 143
Asma, EGPA, HES: elementi di diagnostica differenziale 138
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 138
Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis 137
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: A prospective analysis 137
A 28-Year-Old Man with Stridor and Dyspnea 136
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire 135
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 130
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 128
Set the scene: Key points dell’Inquadramento e diagnosi differenziale dell’EGPA 127
Novel Therapies for ANCA-associated Vasculitis 124
One year in review 2020: vasculitis 123
Quale approccio diagnostico al paziente con iper-eosinofilia? 122
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 121
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 117
Asma ed ipereosinofilia 115
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis 111
A New Era for the Early and Non‐Invasive Diagnosis of Giant Cell Arteritis: The Use of Fast‐Track Ultrasound in Clinical Practice 110
Systemic vasculitis: one year in review 2023 109
Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study 109
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study 108
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 107
Update on Treatment of Antisynthetase Syndrome: A Brief Review 105
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 104
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 103
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 103
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 101
Prevalence of Whipple's disease in north-western Italy 100
ANCA-Associated Vasculitides and Polyarteritis Nodosa - EULAR on-line course on Rheumatic Diseases 99
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 94
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 92
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis 91
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 91
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 90
One year in review 2021: Systemic vasculitis 89
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 87
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 85
An unusual reno-pulmonary complication in the course of systemic sclerosis 83
Striking abdominal aortic stenosis revealing Takayasu's arteritis 81
Erratum: Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis (Rheumatology (2020) 59 (e125-e127) DOI: 10.1093/rheumatology/keaa184) 78
Asma e poliposi nasale: quando preoccuparsi? 74
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study 73
Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review 69
Beyond Oral Anticoagulants Two case reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy 56
Systemic vasculitis: one year in review 2026 39
Totale 8.493
Categoria #
all - tutte 26.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202273 12 9 7 10 12 8 6 1 1 3 1 3
2022/202337 4 12 4 2 1 5 1 2 6 0 0 0
2023/2024334 0 1 1 0 7 9 9 0 131 11 50 115
2024/20252.822 154 265 68 112 167 97 194 83 219 334 298 831
2025/20265.195 610 481 432 559 339 235 661 276 417 455 268 462
Totale 8.493